COVID-19 Resources for Blood Donor Centers
Developed with input from federal regulators, AABB’s regulatory resources are clear, user-friendly tools that help blood centers and transfusion services protect donor and patient safety at each step in the transfusion chain.
Reporting Fatalities Related to Blood Transfusion and Donation to FDA
CBER Reorganization Will Support Growth RMAT Program, Blood Product Development
January 12, 2022
REGULATORY UPDATE: FDA Updates List of Variance Approvals
January 12, 2022
REGULATORY UPDATE: FDA Issues Revised CCP Guidance, AABB Updates CCP Toolkit
January 11, 2022
AABB is now the Association for the Advancement of Blood & Biotherapies. Learn more about our new name and brand – and watch as we evolve throughout 2022.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977